tiprankstipranks
Trending News
More News >
Silex Systems Limited (AU:SLX)
ASX:SLX

Silex Systems Limited (SLX) AI Stock Analysis

Compare
71 Followers

Top Page

AU:SLX

Silex Systems Limited

(Sydney:SLX)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 5.2)
Rating:41Neutral
Price Target:
AU$6.00
▼(-9.64% Downside)
The score is primarily held down by weak financial performance (sharp revenue contraction, ongoing losses, and declining free cash flow). Technical signals also remain bearish with the price below key moving averages and a negative MACD, while valuation is constrained by loss-making results (negative P/E) and no dividend data.
Positive Factors
Licensing business model & partnerships
A licensing and royalty model based on proprietary SILEX technology creates scalable, high-margin revenue streams over time. Strategic industry partnerships bolster credibility, lower commercialization risk and enable recurring income as partners expand uranium enrichment and fuel production.
Low financial leverage
Limited leverage gives the company financial flexibility to fund development and weather operational volatility without large fixed interest burdens. A stable equity base reduces near-term solvency risk and supports continued investment in technology commercialization.
Exposure to HALEU and nuclear fuel demand
Silex operates in a structurally growing segment as advanced reactors and clean-energy transitions increase demand for HALEU. Long-term secular tailwinds for nuclear fuel provide durable addressable market expansion and strategic relevance for its enrichment technology.
Negative Factors
Steep revenue decline and sustained losses
A large recent revenue drop and ongoing negative EBIT/net profit margins weaken the firm's ability to self-fund commercialization and scale operations. Continued losses constrain reinvestment, heighten financing needs, and increase execution risk over the medium term.
Weak free cash flow trajectory
Sharply declining free cash flow reduces internal funding for R&D, capex and licensing support, increasing reliance on external capital. This undermines financial resilience and could delay product commercialization or scaling initiatives over the coming months.
Negative profitability metrics
Sustained negative operating and net margins erode shareholder value and limit the company's ability to generate returns. Without margin recovery, attracting strategic partners or investors and funding long-term commercialization becomes more difficult.

Silex Systems Limited (SLX) vs. iShares MSCI Australia ETF (EWA)

Silex Systems Limited Business Overview & Revenue Model

Company DescriptionSilex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser uranium enrichment technology in Australia. It operates through three segments: Silex Systems, Translucent, and Silex USA. The company also develops cREO, a semiconductor technology. Silex Systems Limited was incorporated in 1987 and is based in Sydney, Australia.
How the Company Makes MoneySilex Systems Limited generates revenue primarily through the licensing of its proprietary SILEX technology, which is used for uranium enrichment. The company earns fees from licensing agreements with partners in the nuclear sector, as well as from sales of enriched uranium products. Key revenue streams include upfront licensing fees, ongoing royalties based on uranium production, and potential sales of nuclear fuel to energy companies. Additionally, SLX has formed strategic partnerships with major players in the nuclear industry, which not only enhances its credibility but also opens up further revenue opportunities through collaborative projects and joint ventures.

Silex Systems Limited Financial Statement Overview

Summary
Silex Systems Limited is facing significant financial challenges, with declining revenues and persistent losses impacting profitability. While the balance sheet shows low leverage, the negative return on equity and declining cash flow growth highlight ongoing operational difficulties.
Income Statement
Silex Systems Limited has experienced significant revenue decline, with a negative revenue growth rate of -44.35% in the most recent year. The company is facing substantial losses, as indicated by negative net profit and EBIT margins. These factors suggest challenges in maintaining profitability and growth.
Balance Sheet
The company's balance sheet shows a low debt-to-equity ratio, indicating limited leverage, which is a positive aspect. However, the return on equity is negative, reflecting ongoing losses and challenges in generating shareholder value. The equity ratio remains stable, suggesting a solid asset base relative to equity.
Cash Flow
Silex Systems Limited has seen a decline in free cash flow growth, with a negative growth rate of -39.62%. The operating cash flow to net income ratio is positive, indicating some ability to convert income into cash. However, the overall cash flow position remains weak due to ongoing losses.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue11.16M6.79M6.11M6.84M4.22M1.92M
Gross Profit-4.13M6.79M-5.09M-1.98M-2.86M-4.42M
EBITDA-7.58M-41.97M-22.27M-5.53M-9.00M-6.61M
Net Income-42.56M-42.56M-22.73M-17.36M-9.46M-6.93M
Balance Sheet
Total Assets98.96M98.96M141.56M152.20M54.12M24.04M
Cash, Cash Equivalents and Short-Term Investments81.96M81.96M117.00M140.74M46.53M19.90M
Total Debt910.20K910.20K1.18M772.14K982.50K38.40K
Total Liabilities8.01M8.01M9.62M3.51M3.57M1.97M
Stockholders Equity90.95M90.95M131.94M148.69M50.55M22.07M
Cash Flow
Free Cash Flow2.86M2.86M5.85M-2.43M287.28K-4.96M
Operating Cash Flow3.02M3.02M6.14M-2.34M412.64K-4.78M
Investing Cash Flow-2.61M-2.61M7.56M-114.40M-40.06M9.79M
Financing Cash Flow403.06K403.06K2.34M114.55M38.20M-199.34K

Silex Systems Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price6.64
Price Trends
50DMA
8.60
Negative
100DMA
7.18
Negative
200DMA
5.42
Positive
Market Momentum
MACD
-0.32
Positive
RSI
39.53
Neutral
STOCH
24.02
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:SLX, the sentiment is Negative. The current price of 6.64 is below the 20-day moving average (MA) of 8.06, below the 50-day MA of 8.60, and above the 200-day MA of 5.42, indicating a neutral trend. The MACD of -0.32 indicates Positive momentum. The RSI at 39.53 is Neutral, neither overbought nor oversold. The STOCH value of 24.02 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:SLX.

Silex Systems Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
AU$1.15B15.4665.33%10.16%25.67%744.90%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
60
Neutral
AU$1.03B-25.15-50.48%333.23%10.83%
58
Neutral
AU$557.27M30.978.20%1.06%-30.96%
45
Neutral
AU$30.86M-0.42-121.41%-1034.67%
43
Neutral
AU$622.46M-66.43-3.19%0.40%-280.65%
41
Neutral
AU$1.85B-37.05-37.20%5.81%-86.09%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:SLX
Silex Systems Limited
6.64
0.92
16.08%
AU:WIN
Widgie Nickel Limited
0.04
0.02
111.76%
AU:BVS
Bravura Solutions Limited
2.56
0.67
35.45%
AU:TYR
Tyro Payments Ltd.
1.05
0.22
25.75%
AU:WBT
Weebit Nano Ltd.
4.91
2.29
87.40%
AU:NXL
Nuix Ltd.
1.86
-3.61
-66.00%

Silex Systems Limited Corporate Events

Silex-Backed GLE Wins US DOE Innovation Funding for Laser Uranium Enrichment
Jan 5, 2026

Global Laser Enrichment, the exclusive licensee of Silex Systems’ SILEX uranium enrichment technology, has been selected by the U.S. Department of Energy for an Innovative Technology Award of up to US$28 million to advance next-generation laser-based uranium enrichment, though it missed out on a separate US$900 million Low Enriched Uranium supply award. GLE reaffirmed its strategy to progress the planned Paducah Laser Enrichment Facility, including re-enriching DOE high-assay depleted uranium tails to significantly boost U.S. domestic uranium and conversion supply, continue NRC licensing efforts, and deepen engagement with industry partners, positioning the SILEX technology as a potentially major future contributor to global nuclear fuel production and U.S. energy security.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$8.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Updates Substantial Holding Changes
Dec 18, 2025

Silex Systems Limited has reported changes in substantial holdings involving its securities. The announcement outlines specific updates to relevant interests and associations, impacting the voting rights and investment management structure. The changes signify a shift in the position of a major stakeholder, which could influence the company’s governance dynamics and potentially affect shareholder relations.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$8.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Announces Change in Director’s Securities Holdings
Dec 17, 2025

Silex Systems Limited has issued a detailed report concerning updates on its director Michael Goldsworthy’s interest in company securities, highlighting the exercise of options and vesting of performance rights under its Employee Incentive Plan. The transactions, tied to meeting key performance milestones like the successful demonstration of its SILEX uranium enrichment technology, underscore the company’s progress in advancing its proprietary technology and its focus on long-term stakeholder value.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$8.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Expands Market Presence with New Securities Quotation
Dec 15, 2025

Silex Systems Limited announced the quotation of 562,500 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of December 15, 2025. This move is part of the company’s strategy to enhance its market presence and provide additional value to its stakeholders by leveraging new opportunities in the securities market.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$8.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

State Street Ceases Substantial Holding in Silex Systems
Dec 4, 2025

Silex Systems Limited has announced that State Street Corporation and its subsidiaries, including State Street Global Advisors, have ceased to be substantial holders in the company as of December 2, 2025. This change in substantial holding may impact the company’s shareholder structure and influence its market dynamics, as State Street’s involvement in the company has been significant.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$8.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Expands Market Presence with New Securities Issuance
Dec 4, 2025

Silex Systems Limited has announced the issuance of 31,000 fully paid ordinary securities, which will be quoted on the Australian Securities Exchange (ASX) under the code SLX. This move is part of the company’s strategy to enhance its financial position and support its ongoing projects, potentially impacting its market presence and offering new opportunities for stakeholders.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$8.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Limited Announces Change in Substantial Holding
Dec 2, 2025

Silex Systems Limited has announced a change in substantial holding, indicating that a previous substantial holder has ceased to hold a significant interest in the company as of November 28, 2025. This change in holding may impact the company’s shareholder structure and could influence voting dynamics and future corporate decisions.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$8.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Limited Announces Change in Substantial Holding
Nov 27, 2025

Silex Systems Limited has announced that a substantial holder has ceased to hold a significant interest in the company as of November 25, 2025. This change in substantial holding could impact the company’s shareholder structure and influence its future strategic decisions, potentially affecting its market position and stakeholder interests.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$8.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Limited Issues New Unquoted Equity Securities
Nov 27, 2025

Silex Systems Limited has announced the issuance of 120,000 unquoted equity securities in the form of options with an exercise price of $4.06, set to expire on June 30, 2030. This move is part of an employee incentive scheme and reflects the company’s strategy to motivate and retain talent, potentially impacting its operational efficiency and market positioning.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$8.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Limited Announces Change in Substantial Holding Status
Nov 19, 2025

Silex Systems Limited has announced a change in its substantial holding status, indicating that State Street Corporation and its subsidiaries have ceased to be substantial holders as of November 17, 2025. This change may impact the company’s voting securities and influence within the market, as the association with a significant financial entity like State Street Corporation is altered.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$10.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Limited Announces Cessation of Securities
Nov 19, 2025

Silex Systems Limited announced the cessation of 15,963 performance rights, which were canceled by agreement between the entity and the holder. This announcement may impact the company’s issued capital and could have implications for stakeholders as it reflects changes in the company’s securities structure.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$10.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Expands Market Presence with New Securities Quotation
Nov 19, 2025

Silex Systems Limited announced the quotation of 110,037 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code SLX. This move is part of the company’s ongoing efforts to enhance its market presence and provide value to its stakeholders by leveraging its advanced technology offerings.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$10.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

State Street Corporation Ceases Substantial Holding in Silex Systems
Nov 12, 2025

Silex Systems Limited has announced that State Street Corporation and its subsidiaries have ceased to be substantial holders of the company’s voting securities as of November 10, 2025. This change in substantial holding may impact the company’s shareholder structure and influence the voting dynamics within the company, potentially affecting its strategic decisions and market positioning.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$9.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Unveils Investor Presentation on Laser Enrichment Technology
Nov 9, 2025

Silex Systems Limited has released a presentation to support its upcoming investor relations activities, highlighting its current and future plans for the commercialization of its third-generation laser-based SILEX uranium enrichment technology. This initiative, in collaboration with Global Laser Enrichment, is a significant step in advancing the company’s position in the nuclear technology market, potentially impacting its operational growth and stakeholder interests.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$9.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Expands Securities Quotation on ASX
Nov 4, 2025

Silex Systems Limited has announced the quotation of 386,400 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of November 4, 2025. This move involves the issuance, transfer, or reclassification of securities due to options being exercised or convertible securities being converted. The announcement signifies an expansion in the company’s securities, potentially impacting its market presence and offering implications for stakeholders regarding the company’s growth and financial strategies.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$10.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems’ Laser Enrichment Technology Achieves Major Milestone
Oct 22, 2025

Silex Systems Limited announced that its SILEX laser-based uranium enrichment technology, licensed to Global Laser Enrichment (GLE), has achieved Technology Readiness Level 6 (TRL-6) following a successful large-scale demonstration. This milestone is a significant step towards commercial deployment, with plans to establish a manufacturing base in the US and develop the Paducah Laser Enrichment Facility in Kentucky. The facility aims to enhance US domestic uranium enrichment capacity and could play a crucial role in nuclear fuel production for current and future reactors, subject to market and regulatory conditions.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$5.50 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Announces Change in Director’s Interest
Oct 20, 2025

Silex Systems Limited has announced a change in the director’s interest, with Michael Goldsworthy acquiring 208,600 Performance Rights. These rights were issued as part of short-term and long-term incentives for FY2026, following shareholder approval at the 2025 AGM. This move reflects the company’s strategic efforts to align executive incentives with its long-term goals, potentially impacting its operational focus and stakeholder interests.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$5.50 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Limited Announces Successful 2025 AGM Resolutions
Oct 17, 2025

Silex Systems Limited announced the results of its 2025 Annual General Meeting, where all resolutions were passed by poll. The resolutions included the re-election of directors, approval of incentive plans, and renewal of takeover provisions, indicating strong shareholder support for the company’s strategic direction. This outcome is likely to reinforce Silex’s position in the market and provide confidence to its stakeholders regarding its governance and future plans.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$5.50 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Limited Explores New Frontiers Amidst Uncertainties
Oct 16, 2025

Silex Systems Limited announced its ongoing development efforts in uranium enrichment technology and its exploration of new commercial applications, including quantum silicon production and medical isotope separation. The company’s projects face various risks and uncertainties, including market conditions, regulatory changes, and geopolitical factors, which could impact their commercial viability and success.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$5.50 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Advances Uranium Enrichment Technology Amid Nuclear Industry Expansion
Oct 16, 2025

Silex Systems Limited has made significant progress in advancing its SILEX uranium enrichment technology, with key milestones achieved in its commercialization efforts, including technology demonstration and regulatory advancements. The company is well-positioned to benefit from the global nuclear industry’s expansion and is actively pursuing opportunities in the US nuclear fuel supply sector. Additionally, Silex is developing its Quantum Silicon Production Project, engaging with potential customers in the quantum computing sector. The company has strengthened its financial position through a successful equity raise, ensuring funding through FY2028.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$5.50 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 07, 2026